Unclaimed brand
Chemomab Therapeutics is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need Our Vision Innovation Translating novel biological insights into transformational treatments Evidence Driven Drug discovery and development that are built on a deep understanding of central fibrotic and inflammatory mediators and
Liking this brand profile? Share this page


Hex Code
Color name
RGB
HSL
CMYK
#1E73BE
Mariner
30, 115, 190
208, 73, 43
84, 39, 0, 25
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#0F0F0F
Cod Gray
15, 15, 15
0, 0, 6
0, 0, 0, 94
Chemomab is a pioneering brand in the field of innovative treatments for patients suffering from fibrosis-related diseases. As a clinical-stage biotechnology company, Chemomab focuses on discovering and developing groundbreaking therapeutics for fibro-inflammatory diseases that have a high unmet need. Their flagship product, CM-101, is a first-in-class monoclonal antibody specifically designed to neutralize the activity of the chemokine CCL24, which plays a crucial role in promoting fibrosis and inflammation.
Promising results have been reported from preclinical and clinical studies of CM-101, demonstrating its safety and potential in treating severe and life-threatening fibro-inflammatory diseases. Notably, Chemomab has shown encouraging results in a Phase 2 liver fibrosis biomarker study in NASH patients and an investigator study in patients with severe lung injury. Under the leadership of experienced professionals, including Co-Founder, CEO, and Chief Scientific Officer Dr.
Adi Mor, Chemomab is dedicated to advancing its innovative pipeline of therapeutic options. They are currently conducting a global Phase 2 trial in primary sclerosing cholangitis patients, with the anticipation of releasing top-line data in the latter part of 2024. With their commitment to revolutionizing the treatment landscape for fibrosis-related diseases, Chemomab is poised to make a significant impact on the lives of patients worldwide
Company type
Public Company
Year founded
2011
Company size
11-50 employees
CCL24-neutralizing monoclonal antibodies
Fibro-inflammatory disease therapeutics
Primary sclerosing cholangitis drug development
Systemic sclerosis drug development
Anti-fibrotic biologics
How do I download the Chemomab Therapeutics logo?
The Chemomab Therapeutics logo comes in two versions: a white logo and an icon. Download as transparent PNG or JPEG.
What does Chemomab Therapeutics' branding look like?
The Chemomab wordmark is a clean, lowercase geometric sans treatment of the name, without a separate emblem or decorative origin motif. Its restrained biotech identity pairs crisp sans-serif typography with a cool blue-and-white palette, scientific and clinical imagery, and spacious, orderly layouts that give prominence to research, pipeline, and corporate information.
What are Chemomab Therapeutics' brand colors?
The Chemomab Therapeutics color palette uses the hex codes #1E73BE, #FFFFFF and #0F0F0F.
The Chemomab Therapeutics name, logos and brand assets are trademarks of Chemomab Therapeutics and its affiliates. Brandfetch isn't affiliated with or endorsed by Chemomab Therapeutics. Their use is subject to Chemomab Therapeutics's brand guidelines.